About Shandong Sinobioway Biomedicine Company

The company is an A-share public company controlled by Unnamed Group and listed on the Shenzhen Stock Exchange. Stock abbreviation: Unnamed Pharmaceutical, stock code: 002581. The company was renamed “Former Zibo Wanchang Technology Co., Ltd.” through major asset restructuring on October 19, 2015. The business segment includes five major biomedical advantage sectors, including interferon, nerve growth factors, biomedical CRO/CDMO, vaccines, and pharmaceutical intermediates. The company has important products including nerve growth factor products, mouse nerve growth factor for injection (trade name: Enjingfu), interferon products, human interferon α2b injections (trade name: amfulon), and human interferon α2b sprays (trade name: tactile). Corporate honors: High-tech Enterprise Certificate; Xiamen Bioengineering Technology Research Center; High-tech Achievements Fair Outstanding Product Award; Xiamen Independent Innovative Seed Enterprise; Fujian Excellent New Product; Fujian Innovative Pilot Enterprise; Green Development Zone, etc.